A Multi-Center, Randomized, Evaluator-Blind, Parallel-Group Evaluation of the Efficacy, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Topical Treatment of Facial Acne Vulgaris.

Trial Profile

A Multi-Center, Randomized, Evaluator-Blind, Parallel-Group Evaluation of the Efficacy, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Topical Treatment of Facial Acne Vulgaris.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2017

At a glance

  • Drugs Benzoyl peroxide/clindamycin (Primary) ; Adapalene/benzoyl peroxide
  • Indications Acne vulgaris
  • Focus Therapeutic Use
  • Acronyms Duetta
  • Sponsors Stiefel Laboratories
  • Most Recent Events

    • 28 Apr 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2008-002359-26).
    • 12 Jul 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 05 May 2010 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top